New trial tests if adding chemo to radiation boosts survival for head and neck cancer patients

NCT ID NCT07125755

First seen Apr 09, 2026 · Last updated Jun 16, 2026 · Updated 8 times

Summary

This phase 3 trial aims to see if adding chemotherapy (cisplatin) to standard radiation therapy after surgery helps people with intermediate-risk head and neck squamous cell carcinoma live longer without the cancer returning. About 386 participants who have had surgery and show certain risk factors will be randomly assigned to receive either chemoradiotherapy or radiotherapy alone. The study is currently recruiting and will track cancer recurrence, spread, and overall survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Guilin Medical College

    RECRUITING

    Guilin, Guangxi, China

    Contact Phone: •••-•••-••••

  • Hainan General Hospital

    RECRUITING

    Sanya, Hainan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, China

    Contact Phone: •••-•••-••••

  • Jiangsu Cancer Hospital

    RECRUITING

    Nanjing, Jiangsu, China

    Contact Phone: •••-•••-••••

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 523000, China

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 523000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiangya Hospital, Central South University

    RECRUITING

    Changsha, Hunan, China

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.